Recommended stocks to buy today: Top stock picks by market experts for 22 May

On to the top stock picks for today as recommended by some of India’s top market experts.

Three stock picks from Ankush Bajaj to watch in the near term

Buy: Motilal Oswal Financial Services Ltd (MOTILALOFS) (current price: ₹800)

• Why it’s recommended: On the daily chart, the stock has given a reverse head and shoulder breakout, also given breakout of rising wedge at ₹788 level. On lower time frame, RSI is trading positively, confirming the trend.
• Key metrics: Resistance level: ₹840– ₹850 (short-term target zone) Support level: ₹775 (pattern invalidation level) Pattern: Reverse head and shoulder + rising wedge breakout RSI: Bullish and confirming trend
• Technical analysis: The stock has broken out of bullish patterns, with price trading above key breakout levels. RSI confirmation on lower time frame adds strength to the setup. Sustaining above ₹788 increases the probability of upside.
• Risk factors: Breakdown below ₹775 may invalidate the breakout. Negative market sentiment or weakness in the financial sector may impact the setup.
• Buy at: ₹800
• Target price: ₹840– ₹850 in 4–5 days
• Stop loss: ₹775

Buy: IDBI Bank Ltd (IDBI) (current price: ₹94.50)

• Why it’s recommended: On the daily chart, the stock has given a rectangle breakout at the ₹88 level and has closed two days higher from that level. On lower timeframe (45 min), ADX is trading above 50 and RSI is above 73, showing strong momentum in price. We can see ₹100+ levels soon.
• Key metrics: Resistance level: ₹100– ₹102 (short-term target zone) Support level: ₹91.50 (pattern invalidation level) Pattern: Rectangle breakout RSI: Strong momentum (73+), ADX above 50
• Technical analysis: The stock has broken out of a consolidation rectangle with strong follow-up buying. Momentum indicators like ADX and RSI on lower timeframes support a sustained upmove. Sustaining above ₹91.50 keeps the bullish structure intact.
• Risk factors: Breakdown below ₹91.50 may invalidate the breakout. Any negative news from the banking sector or broad market weakness may affect momentum.
• Buy at: ₹94.50
• Target price: ₹100– ₹102 in 4–5 days
• Stop loss: ₹91.50

Buy: Ashok Leyland Ltd (ASHOKLEY) (current price: ₹244.60)

• Why it’s recommended: On the daily chart, RSI is trading above the 65 level and ADX is at 22, indicating strengthening momentum. The stock has given multiple breakouts around the ₹236 level, including a falling wedge and a double bottom breakout. On the lower timeframe (45 min), the stock has also given a bullish flag pattern breakout near ₹228, which gives a projected target around ₹270.
• Key metrics: Resistance level: ₹260– ₹262 (short-term target zone) Support level: ₹236 (pattern invalidation level) Pattern: Falling wedge + double bottom + bullish flag RSI: Above 65, ADX at 22
• Technical analysis: Multiple bullish patterns have been confirmed on both higher and lower timeframes. Sustained price action above ₹236 with strengthening RSI and trend momentum indicates a strong bullish setup.
• Risk factors: Breakdown below ₹236 may invalidate the bullish patterns. Broader market weakness or sector-specific news can impact price action.
• Buy at: ₹244.60
• Target price: ₹260– ₹262 in 4–5 days
• Stop loss: ₹236

Two stock recommendations by MarketSmith India

Buy: Krishna Institute of Medical Sciences Ltd. (current price: ₹ 662.75)

● Why it’s recommended: Strong financial performance, operational efficiency

● Key metrics: P/E: 62.89, 52-week high: ₹ 708, volume: ₹ 72.82 crore

● Technical analysis: Reclaimed its 21-DMA

● Risk factors: Regulatory risks, operational challenges in new facilities

● Buy at: ₹ ₹ 662.75

● Target price: ₹ 760 in three months

● Stop loss: ₹ 615

Buy: NTPC Green Energy Ltd (current price: ₹ 106)

● Why it’s recommended: Robust project pipeline and capacity expansion, favourable government policies.

● Key metrics: P/E: N/A, 52-week high: ₹ 155.00, volume: ₹ 255.31 crore

● Technical analysis: Possible 100 DMA

● Risk factors: Capital-intensive nature of the sector

● Buy at:  ₹ 106

● Target price:  ₹ 122 in three months

● Stop loss: ₹ 99

Best stocks to trade as recommended by Trade Brains Portal

Coal India Ltd (Current price: ₹ 405)

• Target price: ₹492 in 12 months
• Stop-loss: ₹ 362
• Why it’s recommended: The company is the largest coal producer in India and operates through 84 mining areas spread over eight states of India. Coal India Ltd. is a “Maharatna" central PSU under the control of the Ministry of Coal, with 63.13% ownership by the Government of India. It has 310 mines and a coal production of 781 million tonnes as of FY25. 

Despite privatization in coal mining through government auction, the company enjoys a monopoly, controlling 48% of India’s proven reserves and contributing 78% of the total domestic coal production.

Revenue from operations stood at Rs. 1,43,369 crore as of FY25, which has been growing at 12% CAGR since FY21. The company has significantly improved its margins through better cost realizations. Net profit margin stood at 24.6% in FY25, up from 15.36% in FY21, with a dividend payout ratio of 46%. Additionally, CIL has distributed ₹5.15 per share as a final dividend for FY25, along with an interim dividend of ₹5.60 and ₹15.75 per share. CIL has a high dividend yield of 6.5% for FY25.

The company expects to achieve 1 billion tons of coal production by 2028-29 and 1.22 billion tonnes of coal production by 2034-35. To achieve this guidance, the company plans to do a capex of ₹16,000 crore to increase its washing capacity, coal mining capacity, first mile connectivity (FMC) projects, and development of rail infrastructure for improving evacuation capabilities.

In November, CIL commissioned its largest solar installation to date, a 50 MW plant at Nigahi under Northern Coalfields Limited, demonstrating its diversification towards renewable energy as India strives to reach 500 GW from non-fossil sources by 2030. Additionally, Coal India plans to supply 4500 MW of carbon-free energy, in a phased manner, to upcoming green ammonia facilities, making it one of the world’s largest renewable energy contracts.

• Risk factor: The company needs environmental and forest approvals, especially in greenfield projects; delays in these approvals impact the operations. CIL is highly susceptible to socio-political factors and regulatory requirements. The company currently has a shortage of last-mile connectivity and logistics infrastructure. Privatization in coal mining may also impact the monopoly status in the long term.

Colgate-Palmolive (India) Ltd (Current price: ₹ 2,659)

• Target price: ₹ 3,250 in 12 months
• Stop-loss: ₹ 2,363
• Why it’s recommended: Colgate-Palmolive India Ltd. is one of the largest oral care companies in India, with a significant presence of over 50% market share in the toothpaste category and a wide distribution network of over 6.5 million outlets. In FY25, Colgate-Palmolive reported revenue from operations of ₹5,999.20 crore, a growth of 6.3% YoY from ₹5,644.18 in FY24. Net profit after tax for FY25 stood at ₹1,436.81 crore as compared to ₹1,323.66 crore, a growth of 8.5% YoY. 

The company has declared a 2nd interim dividend of ₹27 per share, with a total dividend of ₹51 per share for FY25. Colgate continued to maintain product superiority through the relaunch of “Colgate Strong Teeth." The company has introduced India's largest oral health initiative, the Oral Health Movement, which provides personalized dental screening reports powered by AI. 

Demonstrating a commitment to innovation, Colgate has also implemented an AI-ML-driven system to offer tailored product recommendations to 1.7 million retail outlets. This strategy has led to a 14% improvement in product assortment over a two-year CAGR, with participating stores showing 1.2 times higher growth than others. 

According to company, estimates, around 272 million households purchase toothpaste over seven times a year, with an average of 1.5 tubes per purchase, resulting in approximately 2.3 billion tubes sold annually.

The Indian toothpaste market is expected to grow at a CAGR of 4.23% between 2025 and 2034, reaching $2,180 million by 2034. In FY25, the overall revenue of toothpaste and oral health amounted to $1.96 billion, and in terms of per-person revenue, India generated $1.35 per individual in FY25. 

The oral care market is driven by increasing oral health awareness, increased disposable income, and demand for premium dental products. An uptrend in toothpaste consumption is observed, with the rapid expansion of distribution channels across the country and the faster-than-ever evolving e-commerce sector, contributing to the Indian toothpaste market growth. 

The e-commerce market, valued at $125 billion in FY24, is expected to reach $325 billion by 2030, exhibiting a growth rate of 5-17%.

• Risk factor: Colgate faces intense competition from other players like Dabur and Patanjali, especially with the peers offering a variety of toothpastes in the Ayurvedic category, which is gaining more popularity. Additionally, numerous regional and local players offer affordable alternatives to intensify price competition.

The company also faces concentration risk, as approximately 95% of revenues come from the oral care business.

Two stocks to trade, recommended by NeoTrader’s Raja Venkatraman

CANFINOME: Buy CMP and  dips to ₹725, stop ₹715, target ₹810-830

• Why it’s recommended: CANFINHOME's recent results beat estimates, and the stock has shown an encouraging rebound. However, it remains stuck in a consolidation phase, which is keeping a strong lid on price appreciation. Nevertheless, the consistent retention of support levels indicates an underlying intention for prices to move higher in the coming sessions. The formation of steady "higher highs and higher lows" on the charts further highlights a clear bullish intent.
• Key metrics: 
  • P/E: 11.64
  • 52-week high: ₹952
  • Volume: 151.12 K
• Technical analysis: Support at ₹700, resistance at ₹850.
• Risk factors: Interest rates , RBI Policy changes , Property approvals
• Buy: CMP and dips to ₹725.
• Target price: ₹810- 830 in 1 month.
• Stop loss: ₹715.

GABRIEL : Buy  CMP  and dips to 618, stop 608 target ₹705-729

• Why it’s recommended: GABRIEL has been attempting a breakout above the 600 level for several weeks. This breakthrough finally occurred in mid-May, led by a significant surge in trading volume. The stock's consistent support at its Tenkan Sen (TS) and Kijun Sen (KS) bands has been a positive indicator, encouraging this upward trajectory. With the emergence of strong Q4 results, GABRIEL now presents an appealing opportunity for initiating long positions.
• Key metrics: 
  • P/E: 44.54
  • 52-week high: ₹651
  • Volume: 4.49 M
• Technical analysis: Support at ₹556, resistance at ₹755.
• Risk factors: Intense competition , Regulatory Approval
• Buy: CMP  and dips to ₹618.
• Target price: ₹705 - 729 in 1 month.
• Stop loss: ₹608.

 

Raja Venkatraman is co-founder, NeoTrader. His Sebi-registered research analyst registration no. is INH000016223.

MarketSmith India: Trade name: William O'Neil India Pvt. Ltd; Sebi-registered research analyst registration number: INH000015543

Trade Brains Portal is a stock analysis platform. Its trade name is Dailyraven Technologies Pvt. Ltd, and its Sebi-registered research analyst registration number is INH000015729.

Investments in securities are subject to market risks. Read all the related documents carefully before investing. Registration granted by Sebi and certification from NISM in no way guarantees performance of the intermediary or provide any assurance of returns to investors.

Disclaimer: The views and recommendations given in this article are those of individual analysts. These do not represent the views of Mint. We advise investors to check with certified experts before making any investment decisions.